| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.37 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.23 | 0.08 |